Critically, about one third of breast cancer is triple-negative (TNBC), presenting the lack of expression of estrogen receptor α (ER-α), progesterone receptor, and human epidermal growth factor receptor-2 (HER2) [3]. This evidence concerns the gene ESR1 and breast cancer.